Gibson, J.; Dhungana, A.; Pokhrel, M.; Arthur, B.; Suresh, P.; Adebayo, O.; Cottle, R.N.
Validation of Clinical-Grade Electroporation Systems for CRISPR-Cas9-Mediated Gene Therapy in Primary Hepatocytes for the Correction of Inherited Metabolic Liver Disease. Cells 2025, 14, 711.
https://doi.org/10.3390/cells14100711
AMA Style
Gibson J, Dhungana A, Pokhrel M, Arthur B, Suresh P, Adebayo O, Cottle RN.
Validation of Clinical-Grade Electroporation Systems for CRISPR-Cas9-Mediated Gene Therapy in Primary Hepatocytes for the Correction of Inherited Metabolic Liver Disease. Cells. 2025; 14(10):711.
https://doi.org/10.3390/cells14100711
Chicago/Turabian Style
Gibson, Justin, Abishek Dhungana, Menam Pokhrel, Benjamin Arthur, Pramita Suresh, Olumide Adebayo, and Renee N. Cottle.
2025. "Validation of Clinical-Grade Electroporation Systems for CRISPR-Cas9-Mediated Gene Therapy in Primary Hepatocytes for the Correction of Inherited Metabolic Liver Disease" Cells 14, no. 10: 711.
https://doi.org/10.3390/cells14100711
APA Style
Gibson, J., Dhungana, A., Pokhrel, M., Arthur, B., Suresh, P., Adebayo, O., & Cottle, R. N.
(2025). Validation of Clinical-Grade Electroporation Systems for CRISPR-Cas9-Mediated Gene Therapy in Primary Hepatocytes for the Correction of Inherited Metabolic Liver Disease. Cells, 14(10), 711.
https://doi.org/10.3390/cells14100711
